Stryker (SYK) Change in Receivables (2009 - 2026)
Stryker (SYK) posted quarterly Change in Receivables of $177.0 million for Q2 2026, up 256.64% year-over-year from $49.6 million in Q2 2025, and up 139.86% on a QoQ basis from -$444.0 million in Q1 2026.
Stryker (SYK) Change in Receivables (2009 - 2026) Analysis & Trends
Stryker has reported Change in Receivables for 18 years, with the latest figure at $177.0 million in Q2 2026.
- Change in Receivables for Q2 2026 came in at $177.0 million, up 256.64% year-over-year; the trailing twelve-month figure through Jun 2026 was -$137.0 million (down 182.04% YoY), and the FY2025 annual result was -$127.0 million, down 139.56% from the prior year.
- Change in Receivables advanced to $177.0 million in Q2 2026, from -$444.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $441.0 million in Q4 2023 and troughed at -$444.0 million in Q1 2026.
- A 5-year average of $37.8 million and a median of $39.0 million in 2023 frame the typical range for Change in Receivables.
- The widest annual swing landed in 2025, when Change in Receivables tumbled 841.67%; it then surged 256.64% in 2026.
- A 5-year view of Change in Receivables shows it stood at $393.0 million in 2022, then rose by 12.21% to $441.0 million in 2023, then decreased by 12.02% to $388.0 million in 2024, then advanced by 2.32% to $397.0 million in 2025, then sank by 55.42% to $177.0 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $177.0 million in Q2 2026, -$444.0 million in Q1 2026, and $397.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 177.00 Mn |
| Jun 30, 2026 | 177.00 Mn |
| Mar 31, 2026 | -444.00 Mn |
| Mar 31, 2026 | -444.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Mar 31, 2024 | -258.00 Mn |
| Mar 31, 2024 | -258.00 Mn |